Philip Morris CEO: We're pleased with FDA approval of Zyn
Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.
The NFL is more lucrative than ever for players, says Creative Planning managing director Mark Doman
Mark Doman, Creative Planning managing director, joins CNBC's 'Money Movers' to discuss how he provides financial advising to ...
Why a stronger dollar could spell trouble for Big Tech
CNBC's Deirdre Bosa joins 'Money Movers' to break down how a stronger dollar is hitting big tech. Irv Gotti, Grammy-winning producer for Ashanti and Ja Rule, dies at 54 ...
Palantir CEO says China's DeepSeek shows that U.S. needs ‘all-country effort' in AI
Palantir CEO Alex Karp said the rise of competing AI models such as China’s DeepSeek signals the need for the U.S. to speed ...
Markets leave ‘no room for mistakes’ in Trump’s trade war, says famed investor Tudor Jones
Stocks and other financial markets are in a much different place than during Donald Trump’s first term, leaving no room for ...
Wall St ends higher as investors digest earnings, rate cut prospects
All three major stock indexes closed higher on Wednesday, rebounding from declines earlier in the session as investors ...
Stock market decline: Alphabet, AMD earnings spark Nasdaq, S&P 500 dip
US stocks opened lower Wednesday as the Nasdaq and S&P 500 felt impact from Alphabet, AMD and renewed AI worries.
Stock market’s wild ride on Monday could be a microcosm of what to expect in 2025
And late Monday afternoon, a deal was reached with Canada to similarly pause tariffs for at least 30 days. The first 100 days of President Trump’s second term look packed with potential market movers ...
Hosted on MSN4d
Stocks Set to Open Sharply Lower as Trump Imposes Tariffs, U.S. Jobs Data and Earnings in Focus
S&P 500 E-Mini futures (ESH25) are down -1.45%, andMarch Nasdaq 100 E-Mini futures (NQH25) are down -1.79% this morning as ...
CNBC Daily Open: Global central banks are cutting rates — the Fed might not be as inclined
Many economies seem to be settling into a lower-rate environment. That’s in stark contrast with the Federal Reserve, which ...
Pfizer CEO: Our stock is very cheap with lots of upside potential
In an interview on CNBC’s Mad Money, Dr. Albert Bourla said Pfizer (PFE) is focusing on business development to create shareholder value. “We ...
Why Nike Stock Slipped on Friday
Nike (NYSE: NKE) stock slid 2.5% through 10:25 a.m. ET Friday after CNBC (and others) reported Citigroup is downgrading the stock to neutral. Citi is just back from a meeting with new Nike CEO Elliott ...